β-hairpin peptidomimetics
    1.
    发明授权
    β-hairpin peptidomimetics 有权
    &bgr; -hairpin肽模拟物

    公开(公告)号:US08716242B2

    公开(公告)日:2014-05-06

    申请号:US13513550

    申请日:2009-12-04

    IPC分类号: A61K38/12 C07K7/08

    CPC分类号: C07K7/08 A61K38/00 C07K7/64

    摘要: β-Hairpin peptidomimetics of the general formula Cyclo(-Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11-Xaa12-Xaa13-Xaa14-Xaa15-Xaa16-), and pharmaceutically acceptable salts thereof, with Xaa 1-Xaa 16 being amino acid residues of certain types which are defined in the description and the claims, have CXCR4 antagonizing properties and prolonged half-lives in vivo and can be used for preventing HIV infections in healthy individuals or for slowing and halting viral progression in infected patients; or where cancer is mediated or resulting from CXCR4 receptor activity; or where immunological diseases are mediated or resulting from CXCR4 receptor activity; or for treating immunosuppression; or during apheresis collections of peripheral blood stem cells and/or as agents to induce mobilization of stem cells to regulate tissue repair. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.

    摘要翻译: (-Xaa1-Xaa2-Xaa3-Xaa4-Xaa8-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11-Xaa12-Xaa13-Xaa14-Xaa15-Xaa16-)的通式肽模拟物及其药学上可接受的盐 其中Xaa 1-Xaa 16是在说明书和权利要求书中定义的某些类型的氨基酸残基,具有CXCR4拮抗特性和体内延长的半衰期,并且可用于预防健康个体的HIV感染或减缓 并阻止感染患者的病毒进展; 或由CXCR4受体活性介导或产生癌症; 或其中免疫性疾病介导或由CXCR4受体活性产生; 或用于治疗免疫抑制; 或在外周血干细胞的分离采集期间和/或作为诱导干细胞动员以调节组织修复的试剂。 这些肽模拟物可以通过基于混合固相和溶液相合成策略的方法制造。

    BETA-HAIRPIN PEPTIDOMIMETICS
    2.
    发明申请

    公开(公告)号:US20120283196A1

    公开(公告)日:2012-11-08

    申请号:US13513550

    申请日:2009-12-04

    IPC分类号: C07K7/64 C07K1/06 A61K38/12

    CPC分类号: C07K7/08 A61K38/00 C07K7/64

    摘要: β-Hairpin peptidomimetics of the general formula Cyclo(-Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11-Xaa12-Xaa13-Xaa14-Xaa15-Xaa16-), and pharmaceutically acceptable salts thereof, with Xaa 1-Xaa 16 being amino acid residues of certain types which are defined in the description and the claims, have CXCR4 antagonizing properties and prolonged half-lives in vivo and can be used for preventing HIV infections in healthy individuals or for slowing and halting viral progression in infected patients; or where cancer is mediated or resulting from CXCR4 receptor activity; or where immunological diseases are mediated or resulting from CXCR4 receptor activity; or for treating immunosuppression; or during apheresis collections eases of peripheral blood stem cells and/or as agents to induce mobilization of stem cells to regulate tissue repair. These peptidomimetics can be manufactured by a process which is based on a mixed solid-and solution phase synthetic strategy.

    摘要翻译: (-Xaa1-Xaa2-Xaa3-Xaa4-Xaa8-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11-Xaa12-Xaa13-Xaa14-Xaa15-Xaa16-)的通式肽模拟物及其药学上可接受的盐 其中Xaa 1-Xaa 16是在说明书和权利要求书中定义的某些类型的氨基酸残基,具有CXCR4拮抗特性和体内延长的半衰期,并且可用于预防健康个体的HIV感染或减缓 并阻止感染患者的病毒进展; 或由CXCR4受体活性介导或产生癌症; 或其中免疫性疾病介导或由CXCR4受体活性产生; 或用于治疗免疫抑制; 或在血浆分离术收集期间减少外周血干细胞和/或作为诱导干细胞调动以调节组织修复的试剂。 这些肽模拟物可以通过基于混合固相和溶液相合成策略的方法来制造。